9th RSC-BMCS Fragment-based Drug Discovery Meeting

4 March 2024 09:00 - 5 March 2024 17:00, Hinxton, United Kingdom


Introduction
Synopsis
The aim of the 9th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.

Who should attend
This conference is suitable for scientists including chemists, biophysicists, structural biologists, etc., with either existing experience of fragments or wanting to learn about this exciting approach to drug discovery. This international meeting attracts delegates from the UK, several mainland European counties, as well as from the USA, Japan, China and South Korea.

Organising Committee
Emma Grant, GSK
Iva Lukac, Charnwood Molecular
Gordon Saxty, NS-MC Consulting LTD (Chair)
Marianne Schimpl, AstraZeneca
Mary Wheldon, University of Dundee (Treasurer)
Alison Woolford, Astex Pharmaceuticals
Venue
Hinxton Hall

Hinxton Hall, Wellcome Genome Campus, Hinxton, CB10 1RQ, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*